# Vitamin D Supplementation in Breast Cancer Patients

> **NCT06596122** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Abdelrahman Mahmoud** · enrollment: 132 (estimated)

## Conditions studied

- Peripheral Neuropathic Pain

## Interventions

- **DRUG:** Vitamin D (Cholecalciferol )

## Key facts

- **NCT ID:** NCT06596122
- **Lead sponsor:** Abdelrahman Mahmoud
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-15
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06596122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06596122, "Vitamin D Supplementation in Breast Cancer Patients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06596122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*